A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This vital tumor inhibitor protein is frequently lost in several types of tumors, resulting https://bookmarkswing.com/story23736438/vhh-fragments-reactivate-p53-new-new-pathway-for-cancer-therapy